News Brent Saunders ejects from Bausch + Lomb once again Brent Saunders' second stint as chief executive of eye care company Bausch + Lomb has come to an end.
R&D Changing Faces: Pharma and biotech hires, September 2026 There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
News Bayer names Christoph Koenen as its new CMO Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
News PhRMA hires ex-House Majority Leader Eric Cantor as its CEO Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
News FDA nominee Overton dodges questions on Trump influence Trump's FDA nominee Heidi Overton was quizzed on a range of issues at her Senate hearing, including vaccines, the abortion pill, and agency reforms.
R&D Changing Faces: Board of Director and Advisory Board hires, ... Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.